At Tactile Medical, a fundamental value is to earn a fair profit and return value for our shareholders
--
Minimum 15 minutes delayed. Source:
Upcoming Events
Q3 2024 Tactile Medical Earnings Conference Call
NOV 04 2024 5:00 PM EST
Recent News
-
October 21, 2024
Tactile Medical to Release Third Quarter of Fiscal Year 2024 Financial Results on November 4, 2024
MINNEAPOLIS , Oct. 21, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that third quarter of fiscal year 2024 financial results will be
-
October 2, 2024
Tactile Medical Launches Next-Generation Nimbl™ Lymphedema Platform
Initial Launch Focused on Treating Patients Suffering from Upper Extremity Lymphedema MINNEAPOLIS , Oct. 02, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic
-
September 25, 2024
Tactile Medical Announces Positive Clinical Trial Results in Lymphedema Patients Using Advanced Pneumatic Compression Device Therapy
Largest U.S. Prospective Clinical Trial Ever Conducted Demonstrated High Compliance with the Flexitouch® System and Significant Improvements Across Study Endpoints MINNEAPOLIS , Sept. 25, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a